Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048

NCT02419456 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: MK-2048A IVR (Low Dose)
DRUG: MK-2048A IVR (Original Dose)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)